Table 4.

Comparative analysis of the discrimination of liver fibrosis indices for 90–day mortality.

	AUC (95%CI)	ΔAUC(P)	Categorical NRI, % (P)
Each liver fibrosis indices
FIB−4	0.61(0.58–0.64)	NA	NA
APRI	0.56(0.54–0.58)	NA	NA
Forns	0.56(0.53–0.59)	NA	NA
Compartion of liver fibrosis indices
FIB−4 vs. APRI	NA	0.05(<0.001)	28.5(<0.001)
FIB−4 vs. Forns	NA	0.05(<0.001)	33.7(<0.001)
APRI vs. Forns	NA	0.00(0.89)	0.2(0.97)
Model performance
SAHIT	0.79(0.77–0.81)	reference	reference
SAHIT +FIB−4	0.79(0.77–0.82)	0.01(0.03)	11.9(0.02)
SAHIT +APRI	0.80(0.77–0.82)	0.01(0.01)	22.6(<0.001)
SAHIT +Forns	0.79(0.77–0.81)	0.00(0.02)	2.4(0.63)

APRI, Aspartate Aminotransferase/Platelet Ratio Index; FIB−4, Fibrosis−4; SAHIT, full Subarachnoid Hemorrhage International Trialists.